Planned phase II programme of marizomib for solid tumours.

Trial Profile

Planned phase II programme of marizomib for solid tumours.

Planning
Phase of Trial: Phase II

Latest Information Update: 22 Apr 2008

At a glance

  • Drugs Marizomib (Primary) ; Vorinostat
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Sponsors Nereus Pharmaceuticals; Triphase Accelerator Corporation
  • Most Recent Events

    • 22 Apr 2008 New trial record.
    • 19 Apr 2008 Nereus plans to initiate this trial in 2009, following successful completion of the phase Ib trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top